These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20007944)

  • 1. Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study.
    Heller S; Damm P; Mersebach H; Skjøth TV; Kaaja R; Hod M; Durán-García S; McCance D; Mathiesen ER
    Diabetes Care; 2010 Mar; 33(3):473-7. PubMed ID: 20007944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.
    Mathiesen ER; Kinsley B; Amiel SA; Heller S; McCance D; Duran S; Bellaire S; Raben A;
    Diabetes Care; 2007 Apr; 30(4):771-6. PubMed ID: 17392539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the safety and effectiveness of insulin aspart with other bolus insulins in women with pre-existing Type 1 diabetes during pregnancy: A post hoc analysis of a prospective cohort study.
    Mathiesen ER; Alibegovic AC; Anil G; Dunne F; Halasa T; Ivanišević M; McCance DR; Nordsborg RB; Damm P;
    Diabet Med; 2024 Oct; 41(10):e15411. PubMed ID: 39115159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different.
    Goudie RJ; Lunn D; Hovorka R; Murphy HR
    Diabetes Care; 2014 Jun; 37(6):e121-2. PubMed ID: 24855162
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.
    Evers IM; ter Braak EW; de Valk HW; van Der Schoot B; Janssen N; Visser GH
    Diabetes Care; 2002 Mar; 25(3):554-9. PubMed ID: 11874946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus.
    Brunner GA; Hirschberger S; Sendlhofer G; Wutte A; Ellmerer M; Balent B; Schaupp L; Krejs GJ; Pieber TR
    Diabet Med; 2000 May; 17(5):371-5. PubMed ID: 10872536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial.
    Hirsch IB; Bode B; Courreges JP; Dykiel P; Franek E; Hermansen K; King A; Mersebach H; Davies M
    Diabetes Care; 2012 Nov; 35(11):2174-81. PubMed ID: 22933438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
    Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconception episodes of severe hypoglycemia and risk of adverse pregnancy outcomes in pregnant women with type 1 diabetes mellitus.
    Gong Y; Luo S; Shi J; Wei T; Wang J; Liu Y; Yan J; Yang D; Li L; Sun Z; Zheng X; Weng J
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3741. PubMed ID: 37876145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics].
    Gao Y; Pan CY; Zou DJ; Xu ZR; Liu XM; Guo XH
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1960-3. PubMed ID: 19950569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
    Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breastfeeding and the basal insulin requirement in type 1 diabetic women.
    Riviello C; Mello G; Jovanovic LG
    Endocr Pract; 2009 Apr; 15(3):187-93. PubMed ID: 19364685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK.
    Lloyd A; Townsend C; Munro V; Twena N; Nielsen S; Holman A
    Curr Med Res Opin; 2009 Mar; 25(3):599-605. PubMed ID: 19232034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: A population-based cohort study in China.
    Wei Y; Xu Q; Yang H; Yang Y; Wang L; Chen H; Anderson C; Liu X; Song G; Li Q; Wang Q; Shen H; Zhang Y; Yan D; Peng Z; He Y; Wang Y; Zhang Y; Zhang H; Ma X
    PLoS Med; 2019 Oct; 16(10):e1002926. PubMed ID: 31574092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 Diabetes: Management in Women From Preconception to Postpartum.
    Buschur EO; Polsky S
    J Clin Endocrinol Metab; 2021 Mar; 106(4):952-967. PubMed ID: 33331893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus.
    Haahr H; Pieber TR; Mathieu C; Gondolf T; Shiramoto M; Erichsen L; Heise T
    Clin Pharmacokinet; 2019 May; 58(5):639-649. PubMed ID: 30402720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
    Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
    Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.